Jump Financial’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-42,142
Closed -$521K 2012
2025
Q4
$521K Sell
42,142
-271,858
-87% -$2.91M 0.01% 1306
2025
Q3
$2.77M Buy
314,000
+258,757
+468% +$2.01M 0.03% 612
2025
Q2
$352K Buy
+55,243
New +$316K ﹤0.01% 1365
2025
Q1
Sell
-141,938
Closed -$1.36M 1693
2024
Q4
$1.36M Buy
141,938
+104,518
+279% +$959K 0.03% 646
2024
Q3
$312K Sell
37,420
-36,391
-49% -$331K 0.01% 1288
2024
Q2
$503K Buy
+73,811
New +$318K 0.01% 1128
2024
Q1
Sell
-24,353
Closed -$58.4K 1986
2023
Q4
$58.4K Buy
+24,353
New +$57.2K ﹤0.01% 1703
2023
Q3
Sell
-60,863
Closed -$447K 1944
2023
Q2
$447K Buy
+60,863
New +$564K 0.02% 1088
2022
Q3
Sell
-6,907
Closed -$214K 1673
2022
Q2
$214K Buy
6,907
+640
+10% +$21.9K 0.01% 1259
2022
Q1
$257K Buy
+6,267
New +$276K 0.01% 1159
2020
Q4
Sell
-4,200
Closed -$434K 998
2020
Q3
$434K Buy
+4,200
New +$453K 0.09% 375

Other funds holding EBS

Jump Financial's EBS Position: Q1 2026 in Review

Jump Financial sold out of Emergent Biosolutions (EBS) in Q1 2026, closing a stake of 42,142 shares — an estimated $521K sold.

Jump Financial first reported a position in EBS in Q3 2020 and held it in 11 quarters. The position peaked at $2.77M in Q3 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Jump Financial reported no remaining Emergent Biosolutions position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 42,142 Emergent Biosolutions shares in Q1 2026, an estimated $521K.
  • Jump Financial first reported a position in Emergent Biosolutions in Q3 2020 and held it in 11 quarters.
  • Jump Financial's Emergent Biosolutions position peaked at $2.77M in Q3 2025.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.